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Interferon.gamma levels in peritoneal dialysis effluents: Relation to
peritonitis. As peritoneal macrophages require Interferon-y (IFN-y) for
bacterial lysis, IFN-y levels were measured in peritoneal dialysis effluents
(PDE) by a specific radioimmunoassay. High IFN-y levels were found in
patients with peritonitis compared to low levels in patients without
peritonitis ( 9.73 2.63 SE U/mI, N = 39 vs. 0.25 0.04, N = 32). IFN-y
levels varied among different bacteria: Staph. aureus (highest: 23.4 5.7,N = 14), Staph. epidermidis (lower: 3.2 0.8, N = 13), other gram-positive
(1.06 0.32, N 6), gram-negative bacteria (lowest: 0.57 0.30, N = 6).
After treatment of peritonitis levels decreased. In corresponding blood
and PDE samples, by comparing IFN-y levels in 10 peritoneal dialysis
patients (5 with peritonitis, 5 without), levels were raised only in PDE of
patients with peritonitis, implying local IFN-y production. Total lympho-
cytes, T, B and monocyte subsets in patients' plasma and PDE did not
differ, except for a higher number of mononuclear cells in PDE of patients
with peritonitis (P < 0.05). Further investigation of in vitro IFN-y
production in PDE with peritoneal monocytes, syngeneic host lympho-
cytes, and bacteria showed that Staph. aureus induced the highest levels of
IFN-y and E. coli the lowest, in experiments with T cell enriched host
lymphocytic fractions. We conclude that Staph. aureus peritonitis induces
high levels of IFN-y in PDE, possibly by a T cell dependent superantigen
response.
Bacterial peritonitis remains a major problem in patients
undergoing continuous ambulatory peritoneal dialysis (CAPD).
Entry of free-floating environmental (planktonic) bacteria to the
peritoneal cavity occurs via multiple sources. The two principal
routes of entry are touch contamination of dialysate fluids during
the daily exchange procedures or via the exit tunnel of the
peritoneal catheters [1]. Overwhelming numbers of planktonic
bacteria from the above two sources, on entering the peritoneal
cavity, can produce peritonitis when local peritoneal defense
mechanisms fail to induce bacterial killing by peritoneal macro-
phages (PMO) [2]. Recent advances in the use of sterile connect-
ing systems (such as Y-sets) in CAPD patients have caused
significant reductions in the peritonitis rate secondary to touch
contamination, predominantly by Staph. epidermidis [3, 4]. How-
ever, spread of autochthonous skin bacteria from exit tunnel sites
(for example, Staph. aureus) will cause biofilm bacterial coloniza-
tion of peritoneal catheters by these bacteria and remain a
potential source for recurrent peritonitis in a subgroup of CAPD
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patients [5, 6]. It is speculated that peritonitis caused by Staph.
aureus in CAPD patients, which remains a major cause of catheter
loss and morbidity [7], will increase in the future.
Bacterial opsonization and phagocytosis in CAPD patients are
reported to be normal, but in some CAPD patients they may be
defective due to low IgG concentrations in their dialysates [8].
However, recent investigations indicate that, despite adequate
opsonization and bacterial phagocytosis, peritoneal macrophages
(PMO) in some CAPD patients fail to induce bacterial killing of
phagocytosed bacteria due to lack of cytokine interferon-gamma
(IFN-y) generation by peritoneal lymphocytes (PL) [9]. Normally,
after stimulation of PMO by mitogens or bacterial antigens, there
is increased production of cytokine interleukin-1 (IL-i). IL-i
stimulates a subset of lymphocytes to produce interleukin-2 which
then stimulates other types of lymphocytes to produce IFN-y.
Interferon-y can be produced either by T cells or by non-T lym-
phocytes, large granular lymphocytes, or NK cells [10, 11]. Inter-
feron-y has been identified as the lymphokine that activates
human macrophage oxidative metabolism and microbiocidal ac-
tivity [12, 13]. No reports are available in literature for an
objective evaluation of in vivo production of IFN-y levels in
peritoneal dialysis (PD) effluents in response to peritonitis and
with different forms of bacterial strains.
We undertook a prospective study to evaluate IFN-y levels in
PD effluent produced in vivo in patients with CAPD peritonitis in
response to different forms of bacterial strains (gram-positive and
gram-negative) and compared them with levels in PD effluent
from CAPD patients with no peritonitis. We found that IFN-y
levels in PD effluent are often elevated in bacterial peritonitis but
vary in different gram-positive bacterial peritonitis.
Methods
Patient and clinical data
Specimens of spent dialysates were collected from patients
under follow-up for CAPD treatment in the Home Dialysis Unit
of the University of Alberta Hospitals. Patient demographics are
described in three groups, A to C.
Group A, cross sectional study. PD effluents were collected from
71 patients at a single point for cross sectional study. Ages of these
patients varied from 12 to 70 years with an average of 47 years; 27
patients were females. Renal disease varied among these CAPD
patients with chronic renal failure, such as 19 patients had
glomerulonephritis, 27 diabetic nephropathy, 13 polycystic kidney
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disease, 2 chronic pyelonephritis and 10 hypertensive-nephroscle-
rosis. None of the patients had exit site infection at the time of the
study.
Group B, before and after peritonitis study. PD effluents were
collected from a group of five new patients entering into the
CAPD program. For each patient, samples were taken during the
first week of training (basal levels), at the onset of the first episode
of peritonitis and again at the end of antibiotic treatment which
resulted in successful remission of peritonitis. Ages of these
patients varied from 34 to 55 years: two were diabetics, two had
nephrosclerosis, and one had chronic glomerulonephritis Inter-
vals at which peritonitis developed in these five patients after
CAPD treatment began was 6, 7, 8, 12, and 17 weeks, respectively.
Group C, blood and corresponding PD fluid collection. In 10
additional patients undergoing CAPD treatment (5 with perito-
nitis, 5 without peritonitis), blood samples and corresponding PD
effluents were collected to compare cell counts and IFN-y levels
in blood and PD effluent. Ages of these patients varied from 36 to
83 years, four being females. Diagnosis for end-stage renal disease
in these patients was as follows: three were diabetics, three had
hypertension, and four had chronic glomerulonephritis.
Criteria of clinical peritonitis
Criteria of clinical peritonitis included abdominal pain and
cloudy dialysate with all three or two of the additional features
noted below, with or without previous episodes of peritonitis and
antibiotic treatment in the absence of other demonstrable cause
for the abdominal pain.
Additional features were fever, white blood cell (WBC) >200!
mm2 in the peritoneal fluid, and increased fibrin content of
dialysate.
Collection of dialysates
(a) Basal levels of patients with no clinical peritonitis. Overnight
dwell bags (2 liters) were collected during routine visits of each
patient at six to eight week intervals in the Home Dialysis Unit
Clinic of the U of A Hospitals. Aliquots of 150 ml of spent
dialysate were collected aseptically and stored at —20°C until
analysis for IFN-y levels.
(b) During peritonitis. After onset of symptoms the first bag of
spent dialysate was delivered to the dialysis center and sent to the
routine microbiology laboratory of the hospital where 100 ml of
the fluid were taken aseptically for routine microbiologic culture.
The bag was resealed and sent to the research lab where 150 ml of
the fluid were collected and stored at —20°C for study of IFN-'y.
(c) After treatment of peritonitis. Overnight dwell bags of spent
dialysates were collected and processed in the same way as during
peritonitis (b).
(d) Blood samples and corresponding PD effluents. Samples of
blood and corresponding bags of PD effluents were collected in
five patients without peritonitis during their routine visits in the
clinics, and in another five patients when they developed perito-
nitis. Serum samples were used for measurement of IFN-y with an
RIA technique as described below. Collection of PD effluents for
measurement of IFN-y was the same as in a and b. Treatment of
blood and PD effluents for cell counts are described later in the
text.
Radioirnmunoassay (RIA) for interferon-y
The Centocor solid phase radioimmunoassay (RIA) was used
with modification. Dialysate and serum samples were centrifuged
at 1000 X g for 10 minutes to remove any particulate matter that
may have interfered with the results. The supernatants were then
concentrated 20 times using Amicon concentrator kits, In the RIA
procedure, five standards and one control were run with a series
of unknown samples of PD effluents or serum during each experi-
ment. Reaction trays containing standards and control were
subjected to the same manipulation and incubation times as the
PD samples. Beads coated with anti-IFN-'y antibody (mouse,
monoclonal) were dispensed into each reaction well. Added to the
respective wells were 0,2 ml of standards, control, and specimen
samples. Trays were incubated at 22°C to 25°C for two hours after
which the beads were washed three times. 1251-labeled anti-IFN-y
antibody (mouse, monoclonal) was added to each well and trays
again incubated for two hours at room temperature. After repeat-
ing the wash procedure, all liquid was aspirated from the trays.
The beads were then transferred and counted in a gamma
counter. Bound radioactivity is proportional to concentration of
the standards in the specimen within working range of the assay.
A standard curve is obtained in each experiment by plotting
concentration of standards (U/mI) versus bound radioactivity.
Concentrations of the unknown PD fluid, serum samples and
control, when run concurrently with the standards, were deter-
mined from the standard curve and expressed as U/mi. Aliquots of
patient samples, negative and positive for IFN-y, were tested
repeatedly using different master lots as an internal control to
verify day-to-day reproducibility of results. Co-efficient of varia-
tion from different lots was less than 8,5%. The lowest range
obtained by the assay was 0 U/ml and the highest 50 U!ml. By
dilution, a higher positive range could be obtained but was not
necessary for the purposes of this study.
Separation and enumeration of mononuclear cells from blood and
peritoneal effluents of PD patients
Peripheral blood mononuclear cells. Lymphocytes from patients
were separated from heparinized whole blood samples, using the
Ficoll-Hypaque method. Separated lymphocytes were mixed with
2-aminoethylisothiouronium (AET) treated sheep red blood cells
(SRBC) to form rosettes. Rosettes were then isolated by Ficoll-
Hypaque gradient centrifugation which yielded more than 95% of
the T cells. To recover adherent monocyte/macrophage subsets,
lymphocytes were further separated by adhering non-rosetting
lymphocytes to the plastic in a Petri dish. This was done for 60
minutes at 37°C with 5% CO2. Non-adherent cells obtained from
several washings of the Petri dish constituted B cell populations
[14}.
Peritoneal mononuclear cells Total cells from each of the two
liter bags of PD effluent were centrifuged and the pellet resus-
pended. Separation of lymphocytes was done with Ficoll-Hypaque
technique and subsequent further separation of lymphocytes into
subsets was done by following the same procedure as with
peripheral blood lymphocytes (PBL) described above.
In vitro system for IFN-y generation with syngeneic peripheral
blood lymphocytes, peritoneal monocytes, and bacteria
An in vitro system of IFN-y generation in PD effluent was
developed by adding a fixed number of freshly cultured bacteria,
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and peritoneal monocytes (PMO) to varying numbers of synge-
neic (host) lymphocytes in a small volume of PD effluent obtained
from the same patient [15]. Preliminary experiments were done to
establish and validate optimal dosages of bacteria, PMO and
syngeneic lymphocytes for the in vitro system (data not shown).
Thus validated, for subsequent experiments, we kept the number
of bacteria and PMO constant in each experiment and varied the
number of lymphocytes. In each test we added 50 d of freshly
cultured bacterial suspension (1 X i0 cfu/ml) with 5 X iO of
PMO in 10 ml of PD effluent collected from the same patient. To
this we added Ficoll separated syngeneic PBL of the same patient
in T cell enriched (nylon wool separation) and monocyte enriched
(thrombin precipitation) fractions [16], in varying dosages of 1, 2
and 4 X 10 per test. Tests were set up in duplicates and incubated
at 37°C for 18 hours. After centrifugation, PD effluent superna-
tants were tested for IFN-y by the established RIA technique as
described in RL4forIFN-y. A parallel experiment was done with
the same patient's PD effluent, PMO, and lymphocyte fractions, as
described above, as were controls without adding any bacteria in
the test. T cell separation was done in these experiments by nylon
wool technique [16] instead of SRBC rosetting technique [14] to
avoid mitogeneic stimulation of lymphocytes by SRBC. Freshly
cultured bacterial suspensions of Staph. aureus, Staph. epidermidis,
and E. coli were obtained from clinical strains of bacterial cultures
from different PD patients with peritonitis. A Salmonella strain
obtained from a non-PD patient was also used in this experiment.
Results
Results of in vivo production of IFN-y in PD fluids are
presented in three groups: (a) cross sectional data; (b) pre- and
post-treatment levels; (c) comparison of levels in serum and
corresponding samples of PD fluids of the patient. Additionally, in
vitro data for IFN-y production in PD effluent in response to
specific bacteria, PMO and syngeneic host lymphocytes are pre-
sented.
In vivo JFN-y levels
Cross sectional data. We evaluated 32 patients on CAPD who
did not have peritonitis. IFN-y levels in these patients were found
to be very low ( 0.25 0,04 SE U/ml). In 39 patients with clinical
peritonitis where PD effluent was collected before antibiotic
treatment, levels were significantly elevated ( 9.73 2.63 SE
U/mi). Levels in PD effluent were variable in peritonitis due to
different gram-positive bacteria. In patients with peritonitis due to
Staph. aureus, the mean value of IFN-y was 23.45 5.75 SE U/mI.
These levels were significantly higher than in patients with peri-
tonitis due to Staph. epiderinidis (5 3.2 0.84 SE U/ml). Peritonitis
due to other gram-positive organisms (such as Strep. viridans and
diptheroids) induced a low level of in vivo response (5 1.06 0.32
SE U/mi) which was slightly higher than in patients without
peritonitis. We also evaluated six samples of PD effluent from six
different patients with gram-negative peritonitis (Klebsiella N =2,
E. coli N = 4). The levels of IFN-y were quite low (I 0.57 0.30
SE U/mi; Table 1).
Changes in levels with treatment of peritonitis
We monitored levels of IFN-y in five patients starting on CAPD
training (basal values) at the time of development of their first
episode of peritonitis and after successful clinical treatment of
peritonitis. (Details of levels are given in Fig. 1.) Data indicated
Table 1. IFN-y levels (U/mi)
Patient and samples Bacteria
Other
Total gram Gram
without
peritonitis
Total with
peritonitis
Staph.
aureus
Staph.
epidermidis
positive
bacteria°
negative
bacteria"
N 32 39 14 13 6 6
1 0.25 9.73 23.45 3.18 1.06 0.57
SE 0.04 2.63 5.75 0.84 0.32 0.30
Diphtheroids, N = 2; Strep, viridans: N = 4
"Kiebsiella, N = 2; E. coli, N = 4
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Fig. 1. Changes of IFN-y levels (U/mi) in the PDE in five CAPD patients,
before and after antibiotic treatment for first episode of peritonitis. Levels are
represented at three points: A, basal level; B, at onset of first peritonitis
but before antibiotic treatment and; C, at the end of antibiotic treatment.
Different symbols, used for each patient and type of bacterial peritonitis in
each patient, are as follows: BC, Staph. aureus (—U—); WL, Staph. aureus
(—U—); JM, Staph. epidermidis (_*_); KS, Staph. epidermidis (—x—); DM,
diphtheroids (—I—).
that levels increased considerably from basal values with perito-
nitis. After successful treatment of the first episode of peritonitis,
levels fell closer to the basal level in each case. Data confirmed
that levels were maximally elevated with Staph. aureus peritonitis.
Enumeration of mononuclear cell population and IFN-y levels in
the blood and coiresponding PD effluent of the same patient
In 10 PD patients, five with and five without peritonitis, no
quantitative differences existed among patients for total lympho-
cytes, T, B, and monocytes except the total number of lympho-
cytes was higher in PD effluent of patients with peritonitis (P <
0.05 Figs. 2, 3). Levels of IFN-y were not detectable or very low in
serum samples in all patients and in PD effluent of patients
without peritonitis, whereas in four out of five patients with
peritonitis, IFN-y levels were significantly elevated in PD effluent
compared to very low or undetectable levels in patients' corre-
sponding serum samples indicating local intraperitoneal produc-
tion of IFN-y in patients with peritonitis (Figs. 4, 5).
In vitro generation of IFN-y in PD effluent with bacteria, PMO
and syngeneic patient lymphocytes
Results of these experiments showed which cell types are respon-
sible for production of IFN-y in PD effluent in vitro in the
presence of bacteria, PMO and syngeneic host lymphocytes.
A B C
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Fig. 2. Quantitative distribution of peripheral blood lymphocytes (PBL):
total and T, B, and monocyte fractions, as a % of total PBL from 10 CAPD
patients with (, N 5) and without ( N = 5) peritonitis.
Fig. 3. Quantitative distribution of peritoneal mononuclear cells (PMO):
total and % of the T, B, and monocyte fractions separated from the PDE of
the same 10 CAPD patients as represented in Figure 2. Blood and PDE fluid
were collected from the same patient simultaneously and separated
correspondingly for PMO. Significant differences (*) were observed
between total number of PMO in patients with () or without (U)
peritonitis (P < 0.05) but not between fractions of PMO cells.
Several preliminary experiments were done to validate the exper-
imental system in which 1 x 108 cfu/ml of freshly cultured bacteria
was added to 10 ml of PD effluent and 5 X io of PMO obtained
from the same PD patient with no clinical peritonitis. To this were
added 2 x 106 of syngeneic, separated or unseparated fractions of
peripheral blood lymphocytes from the same PD patient (see
Methods). Results of a representative experiment are shown in
Figure 6 with Staph. aureus. Data show T cell enriched fraction (t
9.05 0.650 SD U/mi) induced the highest level of IFN-y in PD
effluent in this in vitro experimental system, besides unseparated
PBL ( 6.65 1.23) and monocyte fractions (14.10 0.56). B cell
enriched fractions and controls with PBL and PD effluent, with or
without Staph. aureus, were negative for IFN-y.
Results of a subsequent and similar experiment are shown in
Figure 7 in which a gram-positive (Staph. aureus) and a gram-
negative bacteria (Salmonella) are compared, also using PD
effluent, PMO and PBL from a single but different CAPD patient
with no peritonitis. Syngeneic host lymphocyte numbers in this in
Serum PD fluid
Fig. 4. Distribution of IFN-y levels in PD fluid and corresponding samples
of serum in five CAPD patients with no peritonitis. Symbols are:
patient #1; (—8—) #2; (—U—) #3, (-8—) #4; (—A—); For patients #1 to #5
there was no growth in PD fluid culture.
/
Fig. 5. Distribution of IFN-y levels in PD fluid and corresponding serum
samples in five CAPD patients with peritonitis. Symbols are: (—•—) patient
#6, E, coli; (—8—) #7, Staph. epi.; (—U—) #8, Staph. epi.; (-8--) #9, Staph.
aur.; (—A—) #10, Staph. epi.
vitro experiment were varied to define the influence of a progres-
sive increase in numbers of lymphocytes and their fractions in
inducing IFN-y. Of the two bacteria used, Salmonella is high in
lipopolysaccharide (LPS) production but low in exotoxins, whereas
Staph. aureus is high in exotoxin but has no LPS. In experiments
with Staph. aureus and T-enriched fractions of PBL, very high
levels of IFN-y in PD effluent were produced in a dose dependent
manner: 5.6, 9.7, 25.0 U/ml with 1, 2 and 4 X 106 cells per test,
respectively. However, monocyte rich fractions produced low
levels of IFN-y (4.0, 5.5, 6.25 U/ml) and unseparated PBL induced
comparable levels of IFN-y as in T-enriched fractions (5.8, 8.3,
18.25 U/mi). No detectable IFN-y levels were noted in experi-
ments with Salmonella with unseparated or separated fractions of
PBL. PD effluent alone, or PD effluent with PMO or PBL without
bacteria, was also negative for IFN-y (negative controls) (Fig. 7).
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Fig. 6. Results of IFN-y levels in PDE in a representative in vitro experi-
ment, where IFN-y levels were induced by interaction of a fixed number of a
freshly cultured bacteria, Staph. aureus (1 x 108/cfulml) with 5 X 104/ml of
PMO in 10 ml of PD effluent (PDE) from the same CAPD patient, were
incubated with 2 x 106 of syngeneicpenpheral blood lymphocytes (PBL) and
1 B, and monocyte fractions of PBL. Control experiments were done with
PDE alone, PDE + PBL and PDE + bacteria. Each test and control were
done in duplicate following an incubation period of 18 hours at 37°C.
IFN-y levels were detected in the PDE supernatants. Mean values and SD
of IFN-y levels in each test are shown in the figure. PDE and PBL were
collected from a stable CAPD patient.
In the next step, the effects of Staph. aureus and Staph.
epidermidis and E. coli, three common bacteria associated with
clinical peritonitis in peritoneal dialysis, were examined in the
same experiment with use of PD effluent, PMO and syngeneic
lymphocytes from a single (but different than described in Fig. 7)
CAPD patient with no clinical peritonitis (Fig. 8). The numbers of
unseparated or separated lymphocytes used in this experiment
were 2 X 106 as determined to be optimal for this experimental
system based on data of our previous experiments (Figs. 6, 7).
Staph. aureus induced high levels of IFN-y in PD effluent by
separated and unseparated lymphocytes in comparison to Staph.
epidetmidis. The highest levels of IFN-y induced by Staph. aureus
were by T cell enriched fractions (. 14.2 4.2SD U/mI) compared
to levels in response to unseparated PBL (5 8.65 1.2 SD) and
monocytes (1 4.4 2.0 SD) (Fig. 6). Levels of IFN-y induced by
PD effluent in the same experiment by Staph. epiderinidis were 1.4,
2.0, and 0.4 U/ml in response to T cell enriched fractions of
lymphocytes, PBL and PMO, respectively. Levels of IFN-y in-
duced by E. co/i were quite low to undetectable in response to
either separated or unseparated syngeneic lymphocytes and were
similar to results of negative controls (Fig. 8).
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Fig. 7. Results of an experiment of in vitro production of IFN-y in the PDE
by Staph. aureus and Salmonella. Symbols are: (0) PBL/S. aur.; (•) TIS.
aur.; (A) mono/S. aur.; (A) PBL/Salm.; (0) T/Salm.; (U) mono/Salm. All
experimental conditions are the same as in Figure 4, except PDE and PBL
were taken from a different CAPD patient who was stable, and two
different bacterial suspensions were used: Staph. aureus—strain from a
different CAPD patient than Figure 4, and Salmonella—a human strain
from a non-CAPD patient. Syngeneic lymphocytes, total, T and monocyte
enriched fractions were added in increasing dosages of 1 X 106, 2 X 106,
and 4 x 106 cells per test. T cell enriched fractions showed highest IFN-y
levels in response to Staph. aureus in a dose dependant manner. Controls
were set up with PDE alone, PDE + PBL in PDE, and PBL + bacteria.
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Fig. 8. In vitro production of IFN-y in PDE by the three bacteria associated
with CAPD peritonitis. Experimental conditions, including controls, are
same as in Figure 4 except 3 bacteria; Staph. aureus (U), Staph. epidermidis(0) and E. co/i () are used. All bacterial strains were collected from
different patients with CAPD associated peritonitis. In this experiment,
PBL and PDE from one syngeneic stable CAPD patient were used. (This
patient was different than patients used for donor cells in experiments
represented in Figs. 6 and 7). Unseparated PBL and T, B, and monocyte
fractions of PBL were used at a dose of 2 X 106/test.
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Although three different experiments shown in Figures 6 to 8
were performed by using peripheral blood mononuclear cells, PD
effluent and PMO from three different stable PD patients with no
clinical peritonitis and freshly cultured bacterial isolates, results of
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each experiment confirmed that the highest level of IFN-y in PD
effluents in vitro was induced in response to Staph. aureus and by
T cell enriched fractions of syngeneic lymphocytes.
Discussion
We report considerable levels of in vivo generated IFN-y in the
spent dialysate of CAPD patients with clinical peritonitis by
means of a reproducible radioimmunoassay (RIA). Our data
indicate that peritoneal infection with different strains of gram-
positive and gram-negative bacteria results in differential induc-
tions of IFN-y levels. This differential response of IFN-y levels in
relation to different bacteria has not been previously reported in
CAPD peritonitis. IFN-y levels were only elevated in PD fluids
during peritonitis and not in corresponding blood samples indi-
cating local intraperitoneal production of IFN-y. Thus, our in vivo
data of IFN-y in PD fluids demonstrate positive correlation with
local inflammatory response to CAPD associated peritonitis.
Detection of IFN-y in PD fluids will therefore be helpful to
understand the pathophysiology of peritonitis associated with PD
in relation to host defense to specific types of bacteria.
Our data additionally indicate, for the first time, the degree of
in vivo IFN-y production in PD effluent not only varies with
different gram-positive bacteria that cause CAPD peritonitis, but
is highest with Staph. aureus peritonitis. This variation reflects
different degrees of cell-mediated immune response induced by
different gram-positive bacterial antigens with PMO and perito-
neal lymphocytes. Experimental mice data indicate soluble bacte-
rial toxins can generate high levels of IFN-yin vivo [10, 11]. Toxins
of Staph. aureus called staphylococcal enterotoxins (SAE) or
superantigens have the ability to bind to the major histocompat-
ibility complex (MHC) Class II molecules of antigen presenting
cells in mice and humans. This binding of SAE protein MHC
ligand to V/3 region of T cells induces activation of T cell subsets
bearing specific Vf3 repertoire [16, 17] which causes activation of
polyclonal T cells leading to a massive release of cytokines,
including IFN-y. This cytokine release causes toxic effect and
inflammation as described in toxic shock syndrome [18]. Staph.
aureus, having the most abundant enterotoxins or superantigens,
can recruit a large number of T lymphocytes inducing release of
cytokines with consequent peritoneal inflammation. This fact is
indicated by the highest levels of IFN-y detected in PD effluent in
peritonitis associated with Staph. aureus in comparison to other
gram-positive bacterial peritonitis. Levels of IFN-y were also high
in peritonitis due to Staph. epidermidis but to a lesser extent than
Staph. aureus (Table 1). Of the four gram-positive bacteria
studied, Staph. aureus, diphtheroids, Strep. viridans and Staph.
epidermidis, the latter was least virulent due to the presence of
fewer staphylococcal toxins. Gram-negative bacteria have no SAE
and induced lowest in vivo levels of IFN-y in CAPD peritonitis.
We observed that IFN-y production in PD fluid is mediated by
T cell enriched fractions of host lymphocytes in vitro, particularly
with Staph. aureus. Although in vitro production of IFN-y in
supernatants of mitogen-stimulated peritoneal lymphocytes has
been reported [19], no information is available regarding the cell
type responsible for IFN-y production by the host lymphocytes in
patients with PD associated peritonitis. Interferon gamma gene
expression is restricted in large granular lymphocytes (LGL) [10,
11]. The relative importance of T cells and LGL in vivo as sources
of IFN-y is unknown. Recent works indicate severe combined
immunodeficient (SCID) mice and athymic nude mice deficient in
T cells are capable of mounting a normal IFN-y response to some
bacterial pathogens [10, 11]. Recent investigations also indicate
that T cells are defective in induced expression of IL-2 and IFN-y
gene in patients with hemodialysis than in patients undergoing PD
treatment [20]. In PD subjects, expression of IL-2 mRNA in
cultured peripheral blood mononuclear lymphocytes was as vig-
orous as in normal subjects, while IFN-y mRNA was even more
strongly inducible. We detected no quantitative differences be-
tween total number of lymphocytes and their subsets in PD
effluents and blood samples among patients with or without
peritonitis. However, the total number of peritoneal monocytes
was higher in PD effluents of patients with peritonitis, but no
differences between fractions of PMO cells indicating a qualitative
response of lymphocytes in PD effluents of patients with perito-
nitis (Figs. 2 to 4). We explored this further in an in vitro
experimental system of IFN-y production in PD fluid to which we
added a fixed number of freshly cultured bacteria and PMO from
the same patient to variable numbers of syngeneic lymphocytes
(Figs. 6 to 8). Highest levels of IFN-y detected in vitro were by T
cell enriched fractions of syngeneic host lymphocytes and Staph.
aureus. We found IFN-'y production by Staph. aureus in PD
effluent appears to be dependent on specific T cell response of
host lymphocytes in the presence of PMO.
With successful treatment of the first episode of peritonitis with
antibiotics, the IFN-y level went down to the basal level, demon-
strating IFN-y levels could be used as an indicator for successful
treatment with antibiotics in CAPD peritonitis (Fig. 1). This is
especially true in difficult cases, as routine cultures will be negative
due to the presence of antibiotics. Interestingly, we noted low
levels of IFN-y in PD effluents in a small number of patients with
recurrent peritonitis caused by the same bacteria (data not
shown). This low in vivo response to IFN-y in some patients with
recurrent peritonitis can occur because of phenotypic changes in
bacteria due to biofilm formation [15] or to intracellular persis-
tence of bacteria. Antibiotics in routine dosages cannot penetrate
biofilm layer [21, 22] or destroy intracellular bacteria [23]. Thus,
low levels of IFN-y in recurrent peritonitis may be an indication
for the use of other drugs in addition to antibiotics, such as,
rifampicin [24] or enzymes like urokinases [25]. To define this
objectively, further studies of IFN-y levels in a large number of
PD patients with recurrent peritonitis are required.
The role of different cytokines, for example, IL-i, TNF, in host
defense against bacterial infection in animals and humans re-
quires further investigation. It is also shown experimentally, that
dependence of one cytokine to another is important in its up- or
down-regulation [26, 27]. However, in CAPD peritonitis the role
of cytokines is not well studied. Recently, it has been demon-
strated that during episodes of peritonitis intraperitoneal secre-
tion of IL-6 becomes markedly but transiently increased com-
pared to levels in serum [28]. We have used IFN-y as a prototype
of cytokines based on our reproducible assay in PD effluent. At
the time of reporting, we do not have data on IL-i, TNF or other
cytokines due to a lack of reproducible assays suitable for use in
PD effluent. We feel it will be important in the future to evaluate
other cytokines in combination with IFN-y in CAPD peritonitis.
Conclusion
In conclusion, we report that in vivo IFN-y levels can be
measured quantitatively in PD effluents from CAPD patients with
peritonitis. Our research shows a definite variation of IFN-y levels
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in different gram-positive bacterial peritonitis; the highest level
detected was in peritonitis due to Staph. aureus. Additionally, high
levels of IFN-y were due to local inflammatory response to
bacteria in the peritoneum and not to a systemic manifestation in
the blood. In vitro experiments suggested this response to Staph.
aureus was mediated by host T cell enriched fractions in response
to the bacteria. Differential response of IFN-y with different
gram-positive bacteria indicates that future study of IFN-y and
other cytokines in PD effluents will provide a new approach for
understanding the role of different bacteria and their interactions
with host defense factors in CAPD associated peritonitis. Despite
many advances, peritonitis still remains a major obstruction to PD
treatment, and any new developments to enhance understanding
its pathophysiology will contribute to its prevention [29].
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